North America Emerges as Largest HIV Diagnosis Market
Access Report Overview: www.psmarketresearch.com/market-analysis/hiv-diagnosis-market
Insights on market segments
As per the findings of the research, based on products, consumable is the largest product category, in the global market. Antibody test has been the largely performed test of the global market, followed by viral load, CD4, early infant diagnosis and viral identification. Diagnostic laboratories have been the largest end user of HIV diagnosis, followed by hospitals, research institutes and others.
Request for Report Sample at: www.psmarketresearch.com/market-analysis/hiv-diagnosis-market/report-sample
North America stands as the largest HIV diagnosis market
Geographically, North America has been the largest market for HIV diagnosis, with the U.S. being the largest contributor to the regional market. Increasing prevalence of HIV/AIDS and advantageous features of point of care instruments and kits has been driving the growth of the North American market. In Europe, the U.K. has been the largest contributor to the market for HIV diagnosis, followed by Germany and France. The market is expected to witness the fastest growth in Asia-Pacific, during 2017 - 2023, owing to increasing cases of HIV rising healthcare expenditure and increasing blood transfusion.
Browse Other Related Report at: www.psmarketresearch.com/industry-report/medical-devices
Key players in the HIV diagnosis market
Some of the key players in the global HIV diagnosis market include Siemens AG, Hoffman La Roche Ltd., Danaher Corporation, Abbott Laboratories, Ltd., Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Alere Inc., Bio-Rad Laboratories and Hologic Inc.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
347, 5th Ave. #1402
New York City, NY - 10016
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America Emerges as Largest HIV Diagnosis Market here
News-ID: 502539 • Views: 401
More Releases from P&S Market Research - Medical Devices
Global Beauty Devices Market Is Driven By Increasing Prevalence Of Skin Diseases
According to the study, the global beauty devices market is likely to grow from $27.8 billion in 2016 to $94.3 billion by 2023. Increasing prevalence of skin diseases, growing aging population, increasing hormonal disorders and high disposable income are some of the major factors driving the growth of the global beauty devices market. The market is further expected to gain revenue due to increasing hormonal disorders and increasing awareness about
Medical Connectors Market 2023 - Global Industry Trends, Analysis, Growth and Fu …
Global medical connectors market is forecasted to attain a value of $2.8 billion by 2023, growing at CAGR of 6.3% during 2017-2023. The growth in the market is boosted by the rising demand for miniaturized connectors, progress in the medical devices industry, increasing geriatric population and surgeries and increasing prevalence of chronic diseases. Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/medical-connector-market/report-sample Based on product, the medical connectors market has been categorized into board to board,
Sterilization Technology Market - Global Industry Analysis, Size, Growth and Dem …
Global sterilization technology market is forecasted to attain $7.5 billion value by 2023, growing at a CAGR of 9.0% during 2017-2023. The boost in demand of sterilization processes is due to the increasing prevalence of healthcare associated infections (HAIs), growing demand for sterilized pharmaceutical products, expanding demand for less invasive surgical procedures, and growing aging population. Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/sterilization-technology-market/report-sample In terms of products & services, the sterilization technology market has
Dialysis Market Analysis, Size, Share, Trends and Future Scope
Dialysis is a process that involves clinical purification of blood, by removing waste such as urea, creatinine, and excess water from blood and is majorly used as an artificial replacement of kidney function in the patients. Dialysis also find its application in patients suffering from chronic renal failure, renal diseases, and kidney transplant. According to the Centers for Disease Control and Prevention (CDC), around 4.9 million adults were diagnosed with
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral